TRIUMEQ用法用量
What is the dosage of Suimeikai? TRIUMEQ is currently the only three-in-one compound drug containing dolutegravir (DTG). It has the characteristics of good tolerance, high resistance barrier and few drug interactions. One tablet per day can significantly reduce the medication burden of AIDS patients, thereby improving patients' medication compliance and significantly improving their quality of life.
For adults and adolescents, TRIUMEQ is currently the only 3-in-1 combination containing dolutegravir (DTG). The recommended dose is one tablet, once daily. Adults or adolescents whose body weight is less than 40 kg should not be given Trimax because Trimax is a fixed-dose tablet and the dose cannot be reduced. TRIUMEQ is currently the only three-in-one combination drug containing dolutegravir (DTG). It is a fixed-dose tablet and cannot be used in patients who require dose adjustment. If one of the active ingredients needs to be discontinued or its dose adjusted, a separate formulation of dolutegravir, abacavir or lamivudine can be used. In these cases, physicians should refer to the respective product information of these drugs.
Elderly patients:
There are limited data on the use of dolutegravir, abacavir, and lamivudine in patients aged ≥65 years, and there is no evidence that older patients require different doses than younger adults. Taking into account age-related changes, such as decreased renal function and changes in hematological parameters, special caution is recommended when administering the drug in this age group.
Kidney damage:
Patients whose creatinine clearance is less than 50mL/min are not recommended to take TRIUMEQ.
Liver damage:
Abacavir is primarily metabolized by the liver. There are no clinical data in patients with moderate or severe hepatic impairment; therefore, use of TRIUMEQ is not recommended unless deemed necessary. For patients with mild hepatic impairment, close monitoring is required, including monitoring of abacavir plasma levels when feasible.
The above is the usage and dosage of TRIUMEQ provided by our medical companion travel overseas medical consulting service company. Patients must not change the dosage on their own and take TRIUMEQ on time.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)